Literature DB >> 5923597

Course of pulmonary sarcoidosis with and without corticosteriod therapy as determined by pulmonary function studies.

O P Sharma, C Colp, M H Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5923597     DOI: 10.1016/0002-9343(66)90216-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  10 in total

1.  Steroid drugs in chest disease.

Authors: 
Journal:  Br Med J       Date:  1972-05-20

2.  The treatment of sarcoidosis.

Authors:  H L Israel
Journal:  Postgrad Med J       Date:  1970-08       Impact factor: 2.401

3.  John McMichael's multisystem interests.

Authors:  D G James; O P Sharma
Journal:  Postgrad Med J       Date:  1968-01       Impact factor: 2.401

4.  Suppression of the alveolitis in pulmonary sarcoidosis by oral corticosteroids.

Authors:  G A Rossi; G B Di Negro; E Balzano; E Cerri; O Sacco; B Balbi; A Venturini; R Ramoino; C Ravazzoni
Journal:  Lung       Date:  1985       Impact factor: 2.584

5.  Exercise testing in pulmonary sarcoidosis.

Authors:  C G Ingram; P C Reid; R N Johnston
Journal:  Thorax       Date:  1982-02       Impact factor: 9.139

6.  Pulmonary function in sarcoidosis.

Authors: 
Journal:  Br Med J       Date:  1967-03-25

Review 7.  Primary care paradigm for management of sarcoidosis, Part 1.

Authors:  R C Young; R E Rachal; B Nelson-Knuckles; C N Arthur; H V Nevels
Journal:  J Natl Med Assoc       Date:  1997-03       Impact factor: 1.798

Review 8.  Treatment of Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

9.  Rate of improvement of pulmonary function in sarcoidosis during treatment with corticosteroids.

Authors:  D S Goldstein; M H Williams
Journal:  Thorax       Date:  1986-06       Impact factor: 9.139

Review 10.  Comprehensive Care for Patients with Sarcoidosis.

Authors:  Catharina C Moor; Vivienne Kahlmann; Daniel A Culver; Marlies S Wijsenbeek
Journal:  J Clin Med       Date:  2020-02-01       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.